Market Tracker

05/23 2:25pm ET

Pernix Therapeutics Holdings Inc (NASDAQ:PTX)

2.51
Delayed Data
As of 2:09pm ET
 -0.1198 / -4.56%
Today’s Change
2.00
Today|||52-Week Range
5.18
+4.59%
Year-to-Date
No recent news for Pernix Therapeutics Holdings Inc.

Today’s Trading

Previous close2.63
Today’s open2.60
Day’s range2.50 - 2.60
Volume72,183
Average volume (3 months)110,073
Market cap$31.1M
Data as of 2:09pm ET, 05/23/2018

Growth & Valuation

Earnings growth (last year)+66.73%
Earnings growth (this year)+30.65%
Earnings growth (next 5 years)+13.60%
Revenue growth (last year)+3.70%
P/E ratioNM
Price/Sales0.18
Price/Book--

Competitors

 Today’s
change
Today’s
% change
NTRPNeurotrope Inc-0.09-0.95%
CDMOPAvid Bioservices Inc-0.00-0.02%
TCONTRACON Pharmaceutica...+0.08+2.97%
AMPEAmpio Pharmaceutical...+0.11+5.21%
Data as of 2:22pm ET, 05/23/2018

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$146.1M
Annual profit (last year)-$77.1M
Net profit margin-52.81%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
John A. Sedor
Senior VP, Chief Financial &
Business Officer
Angus W. Smith
Corporate headquarters
Morristown, New Jersey

Forecasts